Search Results - "Garcilazo, Alexandra"

Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma by Sobrevilla-Moreno, Nora, Rivera-Sánchez, Daniel, García-Ortega, Dorian, López-Macías, Diego, Garcilazo-Reyes, Alexandra, Álvarez-Avitia, Miguel

Get more information

Clinical characteristics of male patients with breast cancer in the Latino population by González-Nuñez, Carlos, Mohar, Alejandro, Reynoso-Noverón, Nancy, Alvarez-Gómez, Rosa María, Chavarri-Guerra, Yanin, Aguilar-Villanueva, Sergio, Guzmán-Trigueros, Raúl, Velázquez-Martínez, Areli, Wegman-Ostrosky, Talía, Porras-Reyes, Fanny, Garcilazo, Alexandra, Arce, Claudia, Bargallo-Rocha, Juan Enrique, Cabrera-Galeana, Paula

“…Breast cancer is the most prevalent cancer type in Mexico, with male breast cancer accounting for only 1% of all breast cancer cases. A limited number of…”
Get full text

Residual Nodal Burden After Neoadjuvant Systemic Therapy in N2-N3 Her2+ and Triple Negative Breast Cancer by Aguilar-Villanueva, Sergio, Bargalló-Rocha, Juan Enrique, Galeana, Paula Cabrera, Esparza-Arias, Nereida, Nuñez, Carlos González, Cruz, Sandy Ruiz, Cano, Alethia Álvarez, Delgado Sánchez, Lizbeth Alejandra, Reyes, Alexandra Garcilazo, Vidal, Carlos Robles, Shaw, Robin

Get full text

PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXICO by Díaz, Andrea Maliachi, Padilla, Daniel Alejandro García, Hernández, Stefan Zilli, Salinas, Claudia Haydée Arce, Díaz, Diana Fabiola Flores, Santos, Juan Antonio Matus, Fernández, José Rodrigo Espinosa, Núñez, Carlos Arturo González, Reyes, Alexandra Garcilazo, Miranda, Alberto Alvarado, Medina, Fernando Ulises Lara, Martínez, Areli Velázquez, Agramonte, Luis André Salinas, Galicia, Julieta Santamaría, Galeana, Paula Anel Cabrera

Get full text

PO113 MORE IS BETTER? DOES EXTENDED TAXANE USE IN COMBINATION WITH TRASTUZUMAB IMPROVE OUTCOMES IN HER2-POSITIVE METASTATIC BREAST CANCER? by Reyes, Alexandra Garcilazo, Salinas, Claudia Haydee Arce, Suarez, Vanessa Leyva, Garcia, Elizabeth Garcia, Diaz, Diana Fabiola Flores, Fernández, José Rodrigo Espinosa, Medina, Fernando Ulises Lara, Medina, Alberto Alvarado, Santos, Juan Antonio Matus, Cruz, Sandy Ruiz, Nuñez, Carlos Arturo Gonzalez, Diaz, Andrea Maliachi, Villanueva, Sergio Aguilar, Galeana, Paula Anel Cabrera

Get full text

Abstract PO3-20-02: Olaparib front line therapy with endocrine therapy in locally advanced unresectable or in metastatic breast cancer: OFELIA TRIAL by Núñez, Carlos Arturo González, Cabrera-Galeana, Paula, Rocha, Juan Enrique Bargalló, Vazquez-Romo, Rafael, Aguilar-Villanueva, Sergio, Garcilazo, Alexandra, Velazquez-Martinez, Areli, Maliachi, Andrea, Rodriguez, Ruben

“…Abstract INTRODUCTION: Currently, patients with recurrent or metastatic hormone-sensitive breast cancer are treated with endocrine therapy (ET) in combination…”
Get full text

Abstract PO4-16-11: De-escalation of anthracyclines during adjuvant therapy based on Oncotype RS: A single institution experience in Mexico City by Núñez, Carlos Arturo González, Cabrera-Galeana, Paula, Rocha, Juan Enrique Bargalló, Vazquez-Romo, Rafael, Aguilar-Villanueva, Sergio, Garcilazo, Alexandra, Velazquez-Martinez, Areli, Maliachi, Andrea, Rodriguez, Ruben, Romero-Bañuelos, Esmeralda

“…Abstract Introduction: In Mexico, hormone positive HER2 negative breast cancer is the most frequent subtype, accounting for 76.6% of cases. For patients…”
Get full text

Abstract P6-05-36: Cost-effectiveness of CDK4/6 inhibitors as a First line Therapy for Metastatic Breast Cancer. A Mexican Cohort by Ramos-Ramírez, Maritza, Guzman-vazquez, Silvia, Dominguez-Esquivel, Vanessa, Espinosa-Fernandez, Jose Rodrigo, Ruiz-Cruz, Sandy, Cabrera-Galeana, Paula, Garcilazo, Alexandra, Cabrera-Miranda, Luis Antonio, Salinas, Claudia Haydee Arce

“…Abstract BACKGROUND. Breast cancer is the most frequent neoplasm worldwide, as reported by GLOBOCAN 2020, there were 2.2 million new cases per year and 680,000…”
Get full text

Long-term outcomes of neoadjuvant treatment in older patients with HER2-positive breast cancer: Evidence from a single center in Mexico by Maliachi Diaz, Andrea, Garcilazo Reyes, Alexandra, González Núñez, Carlos Arturo, Velazquez Martinez, Areli, Flores Diaz, Diana Fabiola, Espinosa Fernandez, Jose Rodrigo, Alvarado Miranda, Alberto, Arce-Salinas, Claudia, Cabrera-Galeana, Paula Anel

“…e12648 Background: The optimal approach to managing breast cancer (BC) in elderly women is still far from certain. These patients are often underrepresented in…”
Get full text